Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Blood Disorder Drug Maker Acquired in $11.6B Deal

The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders. . . . → Read More: Blood Disorder Drug Maker Acquired in $11.6B Deal

Stem Cells Created with Gene Editing

A research lab in San Francisco devised a simpler process for creating stem cells from skin cells in mice with the gene editing technique Crispr. . . . → Read More: Stem Cells Created with Gene Editing

Components Designed to Improve Genetic Circuits

Researchers in Houston, Texas created a set of components like those in electronics that help make synthetic gene circuits more accurate and predictable. . . . → Read More: Components Designed to Improve Genetic Circuits

First MERS Virus Treatment Found Safe

An experimental treatment for Middle East respiratory syndrome, or MERS, infections made from antibodies produced in cattle is shown in a clinical trial to be safe for patients. . . . → Read More: First MERS Virus Treatment Found Safe

Celgene Acquires Cancer Drug Start-Up in $7B Deal

The biopharmaceutical company Celgene Corp. is acquiring Impact Biomedicines Inc., a developer of drugs to treat a type of blood-related cancer, in a deal valued as much as $7 billion. . . . → Read More: Celgene Acquires Cancer Drug Start-Up in $7B Deal

Highly Targeted Opioid Designed to Avoid Side Effects

A pharmacology team decoded complex opioid proteins in the brain to design a compound that can relieve pain, but avoid the dangerous adverse effects causing addiction and overdoses. . . . → Read More: Highly Targeted Opioid Designed to Avoid Side Effects

Biotech, Microsoft Partner on Immune System Diagnostics

A company that analyzes immune system genomics is collaborating with Microsoft Corporation to develop early-stage disease diagnostics. . . . → Read More: Biotech, Microsoft Partner on Immune System Diagnostics

Sangamo, Pfizer Partner on ALS Gene Therapy

Drug maker Pfizer Inc. is licensing and collaborating on a gene therapy technology from Sangamo Therapeutics Inc. to treat amyotrophic lateral sclerosis, or ALS, and a related neurodegenerative disease. . . . → Read More: Sangamo, Pfizer Partner on ALS Gene Therapy

RNA Therapies Start-Up Raises $55.3M in Early Funds

A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round. . . . → Read More: RNA Therapies Start-Up Raises $55.3M in Early Funds

NIH Grant Funds Synthetic Peptide for Severe Asthma

A synthetic peptide, a short chain of amino acids, is being developed as a treatment for severe cases of asthma that do not respond to conventional drugs. . . . → Read More: NIH Grant Funds Synthetic Peptide for Severe Asthma